Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Comparative Study of the Level of Neutralizing Antibodies in People Injecting 4 Types of Covid-19 Vaccine; [بررسیمقایسهایسطح آنتیبادیخنثیکنندهدر افراد تزریقکنندهی4نوع واکسن کووید-] Publisher



Shams Abadi SS1 ; Hoveida L1 ; Naghavi NS1 ; Akbari M2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Microbiology, Falavarjan Branch, Islamic Azad University, Isfahan, Iran
  2. 2. Isfahan Endocrine and Metabolism Research Centre (IEMRC), School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2024


Abstract

Background: Monitoring the disease of COVID-19 and the effectiveness of prevention and control strategies is considered a public health priority. Therefore, the administration of the COVID-19 vaccine has been approved worldwide. The purpose of this review is to describe the current status and quality of COVID-19 vaccines. Methods: In this study, the history and sampling of people injecting vaccines with different platforms at different ages in one year were done to measure the neutralizing antibody titer by ELISA method. The results were analyzed using the ANOVA method, and the significance level of P < 0.01 was determined. Findings: 168 people (109 women and 59 men) with an average age of 40.4 ± 16 years (minimum 18 and maximum 90) participated in the study. The time between vaccination and sampling was 6.7 ± 6.5 (minimum 0.5 and maximum 32) months. Most participants were in the age groups of 21-30 years, and people aged 81-90 were the minimum in the study. No significant relationship between age and antibody response was observed. Sinopharm vaccine had the highest number of injections (80 people), and Barkat vaccine had the lowest number (13 people). Despite significant differences in average antibody levels, all vaccines effectively produced neutralizing antibodies, and high antibody titers could be measured for a long time. Conclusion: Data on vaccine antibody persistence, including potential booster doses or changes in vaccine formulations, are emphasized. Understanding how these vaccines work in producing protective antibodies is influential in evaluating their effectiveness. © 2024 Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. Importance of the Covid-19 Vaccine Booster Dose in Protection and Immunity, Vaccines (2022)
2. Safety, Acceptance, and Hesitancy of Covid-19 Vaccines Among High-Risk Sub-Populations: A Narrative Review, Journal of Pediatrics Review (2023)
3. A Comprehensive Review on Various Aspects of Sars-Cov-2 (Covid-19) Vaccines, International Journal of Preventive Medicine (2022)
4. Seroprevalence of Bordetella Pertussis Among a Nationally Representative Sample of Iranian Pediatric Population: The Childhood and Adolescence Surveillance and Prevention of Adult Noncommunicable Disease-V Study, Journal of Research in Medical Sciences (2021)
5. Hepatitis a Seropositivity Among First-Year Students of the Medical University in Isfahan, Iran, International Journal of Preventive Medicine (2014)
6. The Effect of Covid-19 Vaccination on Reducing the Risk of Infection, Hospitalization, and Death in Isfahan Province, Iran, Iranian Journal of Public Health (2022)
7. Association of Prior Covid‑19 Infection With Risk of Breakthrough Infection Following Vaccination: A Cohort Study in Isfahan, Iran, International Journal of Preventive Medicine (2024)
8. Covid-19 Breakthrough Infections Among Patients With Cancer Receiving Sinopharm Bibp Vaccine, International Journal of Cancer Management (2022)
Experts (# of related papers)
View all Related Experts
Behrooz Ataei (8)
Roya Kelishadi (5)
Other Related Docs
9. Self-Reported Safety of the Bbibp-Corv (Sinopharm) Covid-19 Vaccine Among Iranian People With Multiple Sclerosis, Human Vaccines and Immunotherapeutics (2022)
10. Sars-Cov-2 Seroprevalence Among Health-Care Workers in Isfahan, Iran, Advanced Biomedical Research (2023)
11. Covid-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran, Vaccines (2022)
12. Vaccine-Associated Complications: A Comparative Multicenter Evaluation Among Dental Practitioners and Dental Students—Which Candidate Vaccine Is More Safe in Sars Cov Ii, Gam-Covid-Vac (Sputnik V), Chadox1 Ncov-19 (Astrazeneca), Bbv152 (Covaxin), or Bbibp-Corv(Sinopharm)?, Maxillofacial Plastic and Reconstructive Surgery (2022)
13. Selective Antibody Deficiency and Its Relation to the Igg2 and Igg3 Subclass Titers in Recurrent Respiratory Infections, Iranian Journal of Immunology (2013)
14. Immunogenicity and Safety of Three Who Prequalified (Dtwp -Hb-Hib) Pentavalent Combination Vaccines Administered As Per Iranian National Immunization Plan in Iranian Infants: A Randomized, Phase Iii Study, Indian Pediatrics (2021)
15. Covid-19 Vaccination and Tinnitus: A Case Report, Journal of Kerman University of Medical Sciences (2023)
16. Timing and Delay in Children Vaccination; Evaluation of Expanded Program of Immunization in Outskirt of Iranian Cities, Journal of Research in Health Sciences (2015)
17. Effect of Tetanus-Diphtheria (Td) Vaccine on Immune Response to Hepatitis B Vaccine in Healthy Individuals With Insufficient Immune Response, Journal of Research in Medical Sciences (2015)
18. Should We Consider Another Booster Dose of Measles Vaccine?, Iranian Journal of Medical Sciences (2002)
19. Designing and Psychometric Assessment of the Scale of Factors Influencing Hpv Vaccine Uptake Behaviors in Young Adults, Infectious Agents and Cancer (2022)
20. Seroprevalence of Hepatitis a in Iranian Adolescents: Is It Time to Introduce a Vaccine?, Epidemiology and Infection (2016)
21. Acute Adverse Events Following Immunization With Dtp-Hb-Hib Pentavalent Vaccine in the First Year of Life; [Manifestations Postvaccinales Indesirables Aigues Liees Au Vaccin Pentavalent Dtchb-Hib Au Cours De La Premiere Annee De Vie], Eastern Mediterranean Health Journal (2023)
22. Safety of Sinopharm Vaccine for People With Multiple Sclerosis: Study of Adverse Reactions and Disease Activity, Multiple Sclerosis and Related Disorders (2022)
23. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)
24. Covid-19 Vaccines: Current and Future Challenges, Frontiers in Pharmacology (2024)
25. Evaluation of Anti-Sars-Cov-2 Rbd Antibody Response After Booster Dose of Spikogen® in Individuals With Two Previous Doses of Sinopharm and Its Association With Hla-Dr and -Dq Alleles, Human Immunology (2025)
26. Predictors of Catching Covid-19 Infection During Pandemic Stage in Patients With Multiple Sclerosis (Ms), International Journal of Preventive Medicine (2022)
27. Risk Factors, Clinical, and Laboratory Characteristics of Patients With a Diagnosis of Covid-19, Journal of Emergency Practice and Trauma (2022)
28. Cardiovascular Complications of Covid-19 Vaccines: A Review of Case-Report and Case-Series Studies, Heart and Lung (2023)
29. Seroepidemiology of Hepatitis a Virus Infections in Over 6-Years Population in Isfahan–Iran: A Community-Based Study, Journal of Isfahan Medical School (2007)
30. Monitoring and Active Surveillance of Adverse Events Following the Booster Dose of Azd1222 Vaccine in People Vaccinated With Sinopharm Bbibp-Corv: A Cohort Study, BMC Public Health (2025)
31. Sars-Cov-2 Serology Among People With Multiple Sclerosis on Disease-Modifying Therapies After Bbibp-Corv (Sinopharm) Inactivated Virus Vaccination: Same Story, Different Vaccine, Multiple Sclerosis and Related Disorders (2022)
32. Seroprevalence of Cytomegalovirus Infection and Estimate of Congenital Cytomegalovirus Infection in Isfahan State, Iran: A Population Based Study, Pakistan Journal of Medical Sciences (2013)
33. Covid-19 Infection Risk Following Elective Arthroplasty and Surgical Complications in Covid-19-Vaccinated Patients: A Multicenter Comparative Cohort Study, Arthroplasty Today (2022)
34. Covid-19 Vaccine Boosters: The Good, the Bad, and the Ugly, Vaccines (2021)
35. Survival Analysis for Predictive Factors of Delay Vaccination in Iranian Children, International Journal of Preventive Medicine (2015)
36. Effect of Tetanus-Diphtheria Vaccine on Immune Response to Hepatitis B Vaccine in Low-Responder Individuals, International Journal of Preventive Medicine (2016)
37. Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of Covid.19 Pandemic: A Narrative Review, International Journal of Preventive Medicine (2021)
38. Protective Status of End-Stage Renal Disease Children Against Tetanus and Diphtheria Vaccination, International Journal of Preventive Medicine (2013)
39. Effect of Multiple Sclerosis Disease-Modifying Therapies on the Real-World Effectiveness of Two Doses of Bbibp-Corv (Sinopharm) Vaccine, Journal of the Neurological Sciences (2023)
40. Efficacy and Safety of an Inactivated Virus-Particle Vaccine for Sars-Cov-2, Biv1-Coviran: Randomised, Placebo Controlled, Double Blind, Multicentre, Phase 3 Clinical Trial, BMJ (2023)
41. Efficacy and Side Effects of Sputnik V, Sinopharm and Astrazeneca Vaccines to Stop Covid-19; a Review and Discussion, Immunopathologia Persa (2021)
42. Evaluation of Sars-Cov-2 Serum Level in Patients Vaccinated With Sinopharm/Bbibp-Corv With Kidney Transplantation, Transplantation Proceedings (2022)
43. Immunogenicity of Covid-19 Vaccines in Patients With Diabetes Mellitus: A Systematic Review, Frontiers in Immunology (2022)
44. Hepatitis a Seropositivity Among Newly Admitted Medical Students of Isfahan, Kermanshah, and Hamedan: A Seroprevalence Study, Journal of Research in Medical Sciences (2014)
45. Unraveling the Mystery of Covid-19 Postvaccination Myocarditis: A Systematic Review of Current Cases, International journal of clinical practice (2022)
46. Seroepidemiology of Bordetella Pertussis Infection in Fresh College Students in Iran: A Multicenter Study, Archives of Clinical Infectious Diseases (2014)
47. Sars-Cov-2 Vaccines: A Double-Edged Sword Throughout Rapid Evolution of Covid-19, Cell Biology International (2022)
48. Effectiveness of Bbibp-Corv Vaccine in Preventing Sars-Cov2 Infection and Severe Outcomes in People Living With Multiple Sclerosis: A Population-Based Study, Multiple Sclerosis and Related Disorders (2023)
49. A Prospective Cohort Study Protocol: Monitoring and Surveillance of Adverse Events Following Heterologous Booster Doses of Oxford Astrazeneca Covid-19 Vaccine in Previous Recipients of Two Doses of Sinopharm or Sputnik V Vaccines in Iran, BMC Public Health (2023)
50. Examining the Level of Compliance With Health Protocols in Elementary Schools in Ilam City During the Outbreak of the Sars-Cov-2 in 1400-1401, Iranian Journal of Health and Environment (2023)